Nasal High Flow therapy is being widely adopted in neonatal and pediatric practice. The literature supports the early and integrated use of Nasal High Flow therapy to optimize the patient journey.

Health Economic Benefits are Emerging

If a patient is able to avoid escalation of therapy1,2 and has a shorter length of stay3 in an intensive care setting, this may result in overall cost savings to the hospital1.